Abiopharma

Biotricity strengthens path to scalable profitability for second quarter Fiscal 2026 with sustained margins & operational efficiency

Shareholder Alert: The Ademi Firm investigates whether Cidara Therapeutics, Inc. is obtaining a Fair Price for its Public Shareholders

Financial Statements and Related Announcement :: Third Quarter Results

Resolutions from the Extraordinary General Meeting of Novo Nordisk A/S

Curis to Present at Upcoming 30th Annual SNO Meeting

New SEC Form for ResMed Inc.

Indivior Notification

Forte Biosciences Inc - Forte Biosciences, Inc. Announces Third Quarter 2025 Results and Provides Update

Jaguar Health to Hold Investor Webcast Monday, November 17 at 8:30 AM Eastern Regarding Q3 2025 Financials & Corporate Updates

Trinity Biotech Announces Collaboration to Advance Epigenetic Analysis for EpiCapture Prostate Cancer Test